69 Best Health Tech Startups to Watch in 2024
How do we build this list? TLDR: Using math and experts.
Last update to the database: May 6, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
Sign up to Seedtable Intel to access the entire database
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Developer of treatment for diffuse tenosynovial giant cell tumors. |
$75M · Series B | Bioqube Ventures, Medicxi, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech | B2B | Dublin, Ireland | •••••••••••@synoxtherapeutics.com | |
Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases. |
$139M · Series B | Nextech Invest, EQT Life Sciences, Andera Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Munich, Germany | •••••••••••@tubulis.com | |
Precision oncology treatments developer. |
$21M · Series A | V-Bio Ventures | 1 to 10 | Health Tech, Biotech | Amsterdam, Netherlands | •••••••••••@flindrtx.com | ||
Biomedical research discovery tool. |
$60M · Series B | ICONIQ Growth, Index Ventures, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Robots for surgery. |
$55M · Series B | Sofinnova Partners, Cathay Innovation | 11 to 50 | Health Tech, Hardware, Deep Tech, Robotics, Manufacturing | B2B | Paris, France | •••••••••••@moonsurgical.com | |
AI-powered wound care monitoring platform. |
$3M · Seed | Bpifrance, Elaia, 50 Partners | 11 to 50 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@pixacare.com | |
Skin care telehealth platform. |
$52M · Series B | Village Global, Index Ventures, Headline | 101 to 250 | Health Tech | B2C | London, UK | •••••••••••@getharley.com | |
Oophthalmic gene therapy company to treat blinding retinal illnesses. |
$120M · Series A | Syncona Partners LLP | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@beacontx.com | ||
Gene-editing platform. |
$30M · Series B | Sanofi Ventures, Khosla Ventures, Bpifrance | 11 to 50 | Health Tech, Biotech | Paris, France | •••••••••••@eligo.bio | ||
Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies. |
$8M · Series A | Mercia Asset Management | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@mipdiscovery.com | ||
Digital health platform for women. |
$5M · Seed | Blisce, Vorwerk Ventures | 1 to 10 | Health Tech | B2C, SaaS | Paris, France | •••••••••••@sorella-care.com | |
AI-based platform for clinical trials. |
$2M · Seed | Pfizer Healthcare Hub: London, Bpifrance, Wilco | 1 to 10 | Health Tech, AI | B2B, SaaS | Paris, France | •••••••••••@klineo.fr | |
Workflow automation platform for the life sciences industry. |
$40M · Series B | Local Globe, Dimension, Hummingbird Ventures | 51 to 100 | Health Tech, Machine Learning | B2B | London, UK | •••••••••••@automata.tech | |
Cera Care is a London-based technology-enabled home care company. |
$64M | Oltre Venture | 5001 to 10000 | Health Tech, Mobile, Service Industry, ElderTech | B2B, B2C | London, UK | •••••••••••@ceracare.co.uk | |
Innovative heart pumps manufacturer. |
$28M · Series C | Bpifrance, Sofinnova Partners, Ysios Capital | 51 to 100 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@corwave.com | |
AI software for radiologists. |
$29M · Series B | Bpifrance, Heal Capital, Elaia | 1 to 10 | Health Tech, AI | B2B | Paris, France | •••••••••••@gleamer.ai | |
Digital pet insurance platform. |
$25M · Series B | Balderton Capital, Felix Capital, Inventure | 1 to 10 | Health Tech, Pet Tech | B2C, Marketplace | Stockholm, Sweden | •••••••••••@lassie.co | |
Mnemo Therapeutics specializes in biotechnology and life science. |
$89M · Series A | Sofinnova Partners | 101 to 250 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@mnemo-tx.com | |
Oral macrocycle drug discovery platform. |
$28M · Seed | Novo A/S, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech | B2B | Copenhagen, Denmark | •••••••••••@orbismedicines.com | |
Virtual reality healthcare training platform. |
$12M · Series A | Frog Capital, ACF Investors, QVentures | 1 to 10 | Health Tech, Edtech | B2B, SaaS | London, UK | •••••••••••@oxfordmedicalsimulation.com | |
Payfit allows small and medium enterprises to easily and quickly pay their employees. |
$79M · Series C | Accel, Eurazeo | 251 to 500 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@payfit.com | |
Lab automation robots manufacturer. |
$20M · Series A | R7 Partners, ACME Capital, Y Combinator | 11 to 50 | Health Tech, Robotics | B2B | Copenhagen, Denmark | •••••••••••@reshapebiotech.com | |
Cybersecurity platform. |
$37M · Series A | Northcap | 101 to 250 | Health Tech, Hardware, Cybersecurity, Manufacturing | B2B, SaaS | Paris, France | •••••••••••@sekoia.io | |
SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases. |
$52M · Series A | Ysios Capital | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Paris, France | •••••••••••@sparingvision.com | |
Care orchestration platform. |
$7M · Series A | Explorer Investments, MSM, Brighteye Venture | 11 to 50 | Health Tech | B2B, SaaS | Lisbon, Portugal | •••••••••••@uphillhealth.com | |
Withings is a developer of digital health and wellness smart devices such as fitness trackers and watches. |
$60M · Series B | 2050 | 101 to 250 | Health Tech, Hardware, Sportstech, Mobile, Manufacturing, Wearables | B2B | Paris, France | •••••••••••@withings.com | |
Preventative health care platform. |
$65M · Series A | General Catalyst, Atomico, Lakestar | 11 to 50 | Health Tech | B2C | Stockholm, Sweden | •••••••••••@nekohealth.com | |
Mechatronic guidewires manufacturer. |
$6M · Series A | Forepont Capital Partners, NTI Corporation | 11 to 50 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@basecampvascular.com | |
4D cardiac imaging and navigation platform. |
$21M · Series A | EIC Accelerator, EQT Life Sciences, Atlantic Bridge University Fund | 11 to 50 | Health Tech | B2B, SaaS | Dublin, Ireland | •••••••••••@lumavision.com | |
AI platform to map the human immune system. |
$14M · Series A | Life Extension Ventures, Molten Ventures | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@imubiosciences.com | ||
Generative AI platform for doctors. |
$4M · Seed | Khosla Ventures, Entrepreneur First | 1 to 10 | Health Tech, AI | B2B, SaaS | London, UK | •••••••••••@tortus.ai | |
Developer of imaging catheters based on optical coherence tomography (OCT) for cancer treatment. |
$5M · Series A | Santec Corporation, NLC | 1 to 10 | Health Tech, Deep Tech | B2B | Amsterdam, Netherlands | •••••••••••@scinvivo.com | |
Biosensors developer to combat chronic kidney disease. |
$2M · Pre Seed | Bpifrance, Kima Ventures, Cenitz | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@metyos.com | ||
Open source AI healthcare platform. |
$3M · Seed | Rubio Impact Ventures, Peak Capital, Healthy.Capital | 1 to 10 | Health Tech, Open Source | B2B, SaaS | Amsterdam, Netherlands | •••••••••••@healthsage.ai | |
Digital health platform. |
$1M · Seed | Aviva Ventures | 1 to 10 | Health Tech | B2B, SaaS | London, UK | •••••••••••@healthkey.health | |
Self-sampling technology. |
$2M · Series A | Sciety, We Venture Capital | 1 to 10 | Health Tech | B2C | Stockholm, Sweden | •••••••••••@capitainer.se | |
Clinical-stage biopharmaceutical company. |
$95M · Series A | Lightstone, GV, ARCH Venture Partners | 51 to 100 | Health Tech, Deep Tech | B2C | Dublin, Ireland | •••••••••••@carricktherapeutics.com | |
Ulltrasound-based medical devices manufacturer to treat various brain disorders. |
$4M · Series B | Unorthodox Ventures, EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Hardware | B2C | Paris, France | •••••••••••@carthera.eu | |
Innovative immunotherapies developer for cancer patients. |
$51M | Forbion Capital Partners, Vesalius Biocapital Partners, Bayern Kapital | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | Munich, Germany | •••••••••••@catalym.com | |
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins. |
$50M · Series A | General Catalyst, Khosla Ventures | 1 to 10 | Health Tech, AI, Biotech, Data and Analytics | B2B | London, UK | •••••••••••@charmtx.com | |
Developer of new treatments for central nervous system (CNS) disorders. |
$2M · Seed | Prous Institute for Biomedical Research, Ministry of Science and Innovation of Spain, NextGenerationEU | 1 to 10 | Health Tech | B2B | Barcelona, Spain | •••••••••••@connectatherapeutics.com | |
AI-driven services that aid healthcare providers in delivering timely, accurate care. |
$60M · Series B | Atomico, Eurazeo, Prosus & Naspers | 51 to 100 | Health Tech, Machine Learning | B2B, SaaS | Copenhagen, Denmark | •••••••••••@corti.ai | |
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases. |
$46M | Bioqube Ventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@egle-tx.com | |
At-home blood testing platform for cancer patients. |
$17M · Series A | Business Growth Fund, Parkwalk Advisors | 11 to 50 | Health Tech | B2B | London, UK | •••••••••••@entia.co | |
Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases. |
$30M · Series B | Pureos Bioventures, Karista | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@eyevensys.com | |
Fertility treatment for employees. |
$6M · Seed | Notion Capital, Passion Capital, Tiny VC | 1 to 10 | Health Tech | B2B | London, UK | •••••••••••@fertifa.com | |
Hublo provides software that ease healthcare professionals daily life so that they can focus on taking care of patients. |
$25M · Series A | Revaia, Acton Capital | 51 to 100 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@hublo.com | |
Huma provides a digital health platform used for predictive care and research. |
$25M · Series B | Unilever Ventures, Samsung NEXT | 101 to 250 | Health Tech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@huma.com | |
We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake. |
$22M · Series A | Hoxton Ventures, Atomico, Connect Ventures | 11 to 50 | Health Tech, AI | B2B | London, UK | •••••••••••@kheironmed.com | |
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. |
$25M | Kindred Capital, Atomico | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
Lifen is your simple and secure exchange of medical letters assistant. |
$22M · Series B | Daphni, Partech Ventures, Serena | 11 to 50 | Health Tech, Hardware | B2B, SaaS | Paris, France | •••••••••••@lifen.fr | |
Clinical trials platform. |
$18M · Series A | Valar Ventures, Seedcamp, Atomico | 11 to 50 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@lindushealth.com | |
Developer of prophylactic vaccine against Group B Streptococcus. |
$57M · Series C | EQT Partners, Novo A/S, OrbiMed | 1 to 10 | Health Tech, Biotech | B2B | Copenhagen, Denmark | •••••••••••@minervax.com | |
Digital care. Superpowered. Build engaging relationships with your patients through our machine learning-powered care platform. |
$20M | Firstminute Capital | 11 to 50 | Health Tech, AI, Mobile | B2C | Paris, France | •••••••••••@nabla.com | |
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. |
$30M · Series A | Kindred Capital, Octopus Ventures, Amadeus Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@oribiotech.com | |
Ouihelp is a developer of an online residential assistance platform designed to help seniors in their regular activities at home. |
$31M · Series B | Future Positive Capital, XAnge | 51 to 100 | Health Tech | B2B, B2C, Marketplace | Paris, France | •••••••••••@ouihelp.fr | |
Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform. |
$21M · Series B | AlbionVC, Earlybird Venture Capital, Partech Ventures | 251 to 500 | Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce | B2B | London, UK | •••••••••••@oviva.com | |
Cancer treatment predictor software. |
$14M · Series A | Hoxton Ventures, Octopus Ventures, Fly Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@pearbio.com | |
Quell Therapeutics is a cell therapy company |
$45M · Series A | AlbionVC, Point72 Ventures | 101 to 250 | Health Tech, Edtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@quell-tx.com | |
ReViral is a biotechnology company that develops and offers antiviral therapies for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications. |
$47M | Sofinnova Partners | 1 to 10 | Health Tech, Hardware, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@safeheal.com | |
AI-powered prenatal screening solution. |
$14M · Series A | Bpifrance, Elaia, EIC Accelerator | 11 to 50 | Health Tech, Deep Tech | SaaS | Paris, France | •••••••••••@sonio.ai | |
Sooma Oy is developing a non-invasive brain stimulation device, a treatment option for depression and chronic pain. Mental health. |
$5M · Series A | Verge HealthTech Fund, Voima Ventures | 1 to 10 | Health Tech | Helsinki, Finland | •••••••••••@soomamedical.com | ||
Digital mental health platform for employees. |
$10M · Series A | Bpifrance, Kima Ventures, Alter Equity 3P | 1 to 10 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@teale.io | |
Remote monitoring system for ophthalmic conditions. |
$10M · Series A | Elaia, iBionext, Cap Horn | 11 to 50 | Health Tech | B2C | Paris, France | •••••••••••@tilakhealthcare.com | |
Wandercraft develops and sells the first exoskeleton to walk self-balanced, for inpatient rehab and outpatient daily life. |
$45M · Series C | XAnge | 51 to 100 | Health Tech, Hardware, Deep Tech, Robotics, Manufacturing | B2B | Paris, France | •••••••••••@wandercraft.eu | |
Wellola is a connects clinics & their own clients, anywhere, anytime. |
$2M · Seed | Bay Advisory, Elkstone, Enterprise Ireland | 1 to 10 | Health Tech, Fintech, Video, Payments, Communications | B2B, SaaS | Dublin, Ireland | •••••••••••@wellola.com | |
Comms platform for phamarcists. |
$5M · Seed | Seedcamp, Connect Ventures, Cocoa | 1 to 10 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@faks.co | |
Precision software for eye surgery. |
$8M · Seed | Redalpine | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@hypervisionsurgical.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with – 2,409 in Health Tech.
Seedtable’s take on Health Tech
By Gonz Sánchez Sarmiento
CEO at Seedtable
Health Tech in Europe is a rapidly growing industry that is transforming medicine. Some of the trends powering this transformation include AI in healthcare, an increased focus on patient data, staff wellness, remote healthcare, and wearables. However, Europe is facing substantial challenges in continuing to deliver high-quality healthcare services to its citizens, including ageing populations, cultural shifts, rigid and complex financing models, increasing costs of innovation, a scarcity of skilled personnel, rising health inequalities, and health complexities stemming from climate change. The European Union has implemented the Regulation on Health Technology Assessment (HTA) to improve the quality of HTA across the Union and ensure an efficient use of resources. The European digital health market is predicted to grow at a CAGR of 27.1% from 2020 to 2025, with the UK, Germany, and France being the largest markets. The use of data and technology in the healthcare and life sciences sectors is expected to continue to enhance the industry, with artificial intelligence and machine learning playing a central role. However, the industry is fragmented, especially when it comes to rules and operational standards across the continent, making it challenging to establish a legal basis to allow the exchange of health data.
- Manufacturing... (2505)
- Health Tech... (2416)
- Fintech... (2406)
- Ecommerce... (1781)
- Mobile... (1596)
- AI... (1497)
- Data and Analytics... (1496)
- Business Intell...... (1467)
- Hardware... (1236)
- Climate Tech & ...... (1046)
- Energy & Nuclear... (962)
- Biotech... (947)
- Sales and Marke...... (930)
- Mobility & Tran...... (921)
- Foodtech... (912)
- Proptech & Real...... (893)
- Deep Tech... (807)
- Media and Enter...... (788)
- Crypto & web3... (682)
- Edtech... (651)
- CPG & Consumer ...... (624)
- Privacy and Sec...... (517)
- Developer Tools... (499)
- Gaming... (484)
- Payments... (474)
- Machine Learning... (473)
- Communications... (465)
- Hiring and Recr...... (457)
- Fashion... (425)
- Community & Lif...... (410)
- Agritech... (387)
- Travel Tech... (382)
- Adtech... (369)
- Legal Tech... (350)
- Sportstech... (350)
- Consumer Social... (294)
- Cybersecurity... (284)
- Video... (282)
- Pharma... (272)
- Supply Chain & ...... (270)
- Robotics... (270)
- Creative Tools... (258)
- Productivity Tools... (250)
- Enterprise Soft...... (248)
- Insuretech... (226)
- CRM... (213)
- Future of Work... (210)
- AR / VR... (207)
- Internet of Things... (204)
- Music and Audio... (200)
- Fitness... (190)
- Cloud... (178)
- Service Industry... (161)
- Food Delivery... (134)
- Investing... (130)
- Space Tech... (125)
- Wearables... (112)
- Identity Manage...... (91)
- Navigation and ...... (83)
- Electric Vehicles... (82)
- Publishing... (77)
- ElderTech... (75)
- Personal Finance... (67)
- Messaging... (63)
- Semiconductor... (62)
- Govtech... (62)
- Art... (62)
- Drones... (61)
- Open Source... (55)
- IT Management... (50)
- Pet Tech... (49)
- Quantum Computing... (44)
- FamilyTech & Pa...... (43)
- Esports... (34)
- Genetics... (29)
- UK (445)
- Germany (253)
- France (269)
- Spain (154)
- Sweden (165)
- Switzerland (150)
- Netherlands (71)
- Italy (50)
- Denmark (93)
- Finland (69)
- Norway (37)
- Ireland (51)
- Belgium (43)
- Poland (44)
- Scotland (48)
- Austria (32)
- The Netherlands (22)
- London (241)
- Paris (129)
- Berlin (100)
- Stockholm (99)
- Copenhagen (78)
- Barcelona (71)
- Amsterdam (41)
- Munich (54)
- Madrid (40)
- Oslo (22)
- Helsinki (33)
- Zürich (47)
- Dublin (39)
- Milan (21)
- Cambridge (76)
- Vienna (29)
- Brussels (25)
- Lyon (30)
- Manchester (24)
- Glasgow (31)
- Geneva (23)
- Lausanne (38)
- Oxford (24)
- Basel (23)